Review



de-identified clinformatics ® data mart  (Optum Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Optum Inc de-identified clinformatics ® data mart
    De Identified Clinformatics ® Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics ® data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics ® data mart - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    de-identified clinformatics ® data mart  (Optum Inc)
    90
    Optum Inc de-identified clinformatics ® data mart
    De Identified Clinformatics ® Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics ® data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics ® data mart - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    optum’s de-identified clinformatics® data mart database (clinformatics)  (Optum Inc)
    90
    Optum Inc optum’s de-identified clinformatics® data mart database (clinformatics)
    Optum’s De Identified Clinformatics® Data Mart Database (Clinformatics), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/optum’s de-identified clinformatics® data mart database (clinformatics)/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    optum’s de-identified clinformatics® data mart database (clinformatics) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    de-identified clinformatics® data mart  (Optum Inc)
    90
    Optum Inc de-identified clinformatics® data mart
    De Identified Clinformatics® Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics® data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics® data mart - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    de-identified clinformatics data mart  (Optum Inc)
    90
    Optum Inc de-identified clinformatics data mart
    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified <t>Clinformatics</t> ® Data Mart; US, United States.
    De Identified Clinformatics Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics data mart - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    de-identified clinformatics® data mart (optum cdm)  (Optum Inc)
    90
    Optum Inc de-identified clinformatics® data mart (optum cdm)
    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified <t>Clinformatics</t> ® Data Mart; US, United States.
    De Identified Clinformatics® Data Mart (Optum Cdm), supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics® data mart (optum cdm)/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics® data mart (optum cdm) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    clinformatics optum’s de-identified clinformatics data mart database  (Optum Inc)
    90
    Optum Inc clinformatics optum’s de-identified clinformatics data mart database
    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified <t>Clinformatics</t> ® Data Mart; US, United States.
    Clinformatics Optum’s De Identified Clinformatics Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clinformatics optum’s de-identified clinformatics data mart database/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    clinformatics optum’s de-identified clinformatics data mart database - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    de-identified clinformatics© data mart  (Optum Inc)
    90
    Optum Inc de-identified clinformatics© data mart
    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified <t>Clinformatics</t> ® Data Mart; US, United States.
    De Identified Clinformatics© Data Mart, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics© data mart/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics© data mart - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    de-identified clinformatics data mart database  (Optum Inc)
    90
    Optum Inc de-identified clinformatics data mart database
    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified <t>Clinformatics</t> ® Data Mart; US, United States.
    De Identified Clinformatics Data Mart Database, supplied by Optum Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/de-identified clinformatics data mart database/product/Optum Inc
    Average 90 stars, based on 1 article reviews
    de-identified clinformatics data mart database - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart. Note: The incidence and prevalence numbers for CAD were relatively lower; hence, these numbers were not shown on the graphs.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart. Note: The incidence and prevalence numbers for CAD were relatively lower; hence, these numbers were not shown on the graphs.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). AIHA, autoimmune hemolytic anemia; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). AIHA, autoimmune hemolytic anemia; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: (A) Optum CDM (2023), (B) MORE 2 Registry (2022), and (C) Medicare FFS (2021). CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart; US, United States. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques:

    AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart.

    Journal: PLOS One

    Article Title: Prevalence and incidence of primary autoimmune hemolytic anemia and cold agglutinin disease in the United States, 2016–2023

    doi: 10.1371/journal.pone.0323843

    Figure Lengend Snippet: AIHA, autoimmune hemolytic anemia; CAD, cold agglutinin disease; FFS, Fee for Service; MORE 2 , Medical Outcomes Research for Effectiveness and Economics; Optum CDM, Optum de-identified Clinformatics ® Data Mart.

    Article Snippet: This retrospective study aims to update the epidemiology of AIHA and CAD in the US from 2016 to 2023 by separately analyzing administrative claims data from Optum’s de-identified Clinformatics ® Data Mart (Optum CDM), Inovalon’s Medical Outcomes Research for Effectiveness and Economics (MORE 2 ) Registry, and Medicare Fee for Service (FFS).

    Techniques: